AllTrials campaign

The Myrovlytis Trust is pleased to be supporting the AllTrials campaign. We consider that all clinical trials should be registered and results published. We support complete transparency for all data underlying clinical studies particularly in rare disease research where opportunity for study and replication is limited. Read our support statement here and learn more about the campaign here.